↓ Skip to main content

Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study

Overview of attention for article published in Frontiers in oncology, June 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
1 news outlet
twitter
16 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study
Published in
Frontiers in oncology, June 2023
DOI 10.3389/fonc.2023.1075823
Pubmed ID
Authors

Ryan C. Augustin, Ziyu Huang, Fei Ding, Shuyan Zhai, Jennifer McArdle, Anthony Santisi, Michael Davis, Cindy Sander, Diwakar Davar, John M. Kirkwood, Greg M. Delgoffe, Allison Betof Warner, Yana G. Najjar

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 25%
Student > Bachelor 1 13%
Researcher 1 13%
Lecturer 1 13%
Unknown 3 38%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Biochemistry, Genetics and Molecular Biology 1 13%
Immunology and Microbiology 1 13%
Medicine and Dentistry 1 13%
Unknown 4 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2024.
All research outputs
#1,973,161
of 26,180,352 outputs
Outputs from Frontiers in oncology
#417
of 22,922 outputs
Outputs of similar age
#36,647
of 379,737 outputs
Outputs of similar age from Frontiers in oncology
#11
of 1,089 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,922 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 379,737 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 1,089 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.